From Access to Excellence: How Outcome-Driven Care Is Redefining Healthcare in the UAE

1. You came from a background leading international operations at Cleveland Clinic before joining The Brain & Performance Centre. How has that experience shaped your view on what healthcare expansion should actually look like, beyond just adding more facilities?

Most healthcare expansion fails because it replicates infrastructure, not outcomes. Adding facilities increases access, but it also introduces variability. Without a clearly defined model of care, supported by structured protocols, data tracking, and clinical alignment, you don’t scale quality — you dilute it.

At The Brain & Performance Centre – A DP World Company, expansion is not about footprint. It’s about building a model that can consistently deliver measurable outcomes, regardless of where it is applied. That’s what defines meaningful growth in healthcare.

2. Your programme follows a structured arc: from a three-day assessment, through a 12-week treatment protocol, to a post-assessment and ongoing remote monitoring. Was this continuity model a deliberate design choice, or did it evolve from what patients actually needed?

It was deliberately designed, and quickly validated by patient behaviour.

In most healthcare models, patients are assessed, given recommendations, and then expected to manage implementation on their own. That’s where outcomes break down. Without structure, adherence drops — not because patients lack intent, but because the system isn’t designed to support follow-through.

The three-phase model addresses that directly. The assessment establishes a precise baseline. The 12-week protocol delivers controlled, multidisciplinary intervention. The post-assessment and remote monitoring ensure that improvements are measured and sustained. Without continuity, you may see short-term improvement. You don’t get durable change.

3. Many healthcare providers still measure success by the number of patients seen or procedures performed. How do you define a successful patient outcome at The Brain & Performance Centre and how do you track it over time?

We define success through functional change that is objectively measured and

sustained. That includes improvements in cognitive performance, physical capacity and daily function. But more importantly, it’s whether those improvements translate into real-world outcomes — returning to work, improving performance, regaining independence.

We measure before and after the programme, and we continue measuring beyond discharge. If the improvement doesn’t hold, we don’t consider it a successful outcome.

4. You received the Human-Centric Healthcare Leadership Award recognising your Approach to combining cutting-edge science with deeply personalised care. What does “human-centric” actually mean operationally — what does it look like on the floor, day to day?

Human-centric care is not about having multiple specialists involved. It’s about having a single, coordinated plan that adapts to the patient in real time.

Operationally, that means multidisciplinary teams working against one integrated protocol, not delivering isolated interventions. It means continuously adjusting treatment based on how the patient is responding, rather than following a fixed pathway. It also extends beyond treatment. It’s how progress is communicated, how expectations are managed, and how continuity is maintained after the patient leaves the centre. Personalisation is not a layer on top of care. It’s built into how the system operates.

5. Your programme integrates hyperbaric oxygen therapy with cognitive

assessments, physical conditioning, nutritional planning, and remote follow-up. How do you prevent that level of integration from becoming overwhelming for patients, and how do you keep them engaged across the full journey?

The complexity sits behind the system, not with the patient. From the patient’s perspective, the programme is structured into a clear, manageable rhythm. Each component is introduced with a defined purpose — whether it’s supporting neuroplasticity, improving mitochondrial function, or enhancing physical capacity.

When patients understand why they are doing something, engagement increases. When they can see measurable progress — in cognitive scores, physical performance, or clinical markers — adherence follows. Engagement is not driven by motivation alone. It’s driven by clarity and visible results.

6. Dubai has seen a 25% increase in clinics and hospitals in recent years, with an ambition to attract 500,000 medical tourists annually. Now that scale and accessibility have largely been achieved in the UAE, what does the next stage of differentiation look like and where does The Brain & Performance Centre fit in that picture?

The UAE has already established strong access to healthcare. The next phase is about credibility and outcomes. Medical tourism doesn’t sustain on availability alone. Patients are increasingly selective. They want evidence that the care they receive will deliver measurable results, particularly in specialised areas like brain health, longevity, and performance.

The next stage isn’t about attracting more patients. It’s about proving that the care delivered justifies why they travelled in the first place. Our position is clear. We don’t compete on volume. We focus on a specialised model where outcomes can be measured, tracked, and demonstrated.

7. The UAE is increasingly associated with quality-of-life and longevity ambitions. Do you find that patients here are arriving earlier, more proactively, than patients elsewhere, and what does that mean for how you design care pathways?

Yes, and it changes how care needs to be designed.

In many healthcare systems, patients enter late — when conditions have already progressed. In the UAE, we are seeing more patients come in earlier, either at the first signs of decline or with a focus on optimisation. Most healthcare systems are not built for that type of patient. They are designed for mintervention, not performance.

That shift allows us to focus not only on recovery, but on slowing progression, improving baseline function and enhancing performance. It moves healthcare from reactive treatment to proactive management.

8. The Brain & Performance Centre recently became the first facility in the Middle East and one of only three outside the US to receive accreditation from the Undersea and Hyperbaric Medical Society. What doors does that kind of credentialing open, both for patients and for how the broader healthcare system views what you do?

Accreditation introduces standardisation into an area that has historically lacked it. For patients, it provides assurance that treatment is delivered under internationally recognised clinical protocols, with defined safety and quality benchmarks.

For the broader healthcare system, it creates a pathway for integration — whether through referrals, clinical collaboration, or future reimbursement models. It allows hyperbaric oxygen therapy to move from being viewed as an alternative option to being recognised as part of a structured, evidence-based clinical approach.

9. If you had to identify the single biggest gap between what patients expect from a healthcare journey today and what most providers are actually delivering, what would it be?

Healthcare still operates in episodes, while patients expect a continuous journey. Patients expect coordination — where diagnosis, treatment, and follow-up are connected and actively managed. What they often experience instead is fragmentation, with limited continuity and little long-term tracking.

Closing that gap requires a structural shift. Care needs to be designed as a continuous pathway, with clear ownership, measurable milestones, and ongoing engagement.

That’s where healthcare needs to evolve.